Key Insights

Highlights

Treatment Research

1 treatments under study, led by Allogeneic Hematopoietic Cell Transplantation

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00185523Terminated

Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)

Showing all 1 trials

Research Network

Common Treatments

  • Allogeneic Hematopoietic Cell Transplantation1

Active Sponsors

  • Stanford University1

Related Conditions

  • Leukemia Acute Myeloid Leukemia Aml1
  • Leukemia Lymphocytic Acute1
  • Leukemia Acute Promyelocytic Leukemia Apl1
  • Leukemia1
  • Leukemia Chronic Lymphocytic Leukemia Cll1

Activity Timeline